Reta-Peptide CJC-1295
As of 9 Aug 2026, Finnrick has published 9 independent lab tests of CJC-1295 from Reta-Peptide: 3 passed and 6 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 13 Jul 2026. The current Finnrick rating for Reta-Peptide CJC-1295 is 31%.
Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.
Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.
| Date | Result | Certificate |
|---|---|---|
| 13 Jul 2026 | Pass | Certificate hxaa977 |
| 13 Jul 2026 | Fail | Certificate 4h4u6rh |
| 6 Mar 2026 | Fail | Certificate qgkj5fq |
| 26 Jan 2026 | Fail | Certificate 8udhkqc |
| 6 Dec 2025 | Fail | Certificate vbsh3s2 |
| 17 Nov 2025 | Pass | Certificate yxhc8jt |
| 17 Nov 2025 | Pass | Certificate aggu2ny |
| 18 Sep 2025 | Fail | Certificate 99aacnp |
| 24 Jul 2025 | Fail | Certificate 7a3w55q |